Home
Cepheid

Cepheid Market Share Analysis for May 2026

Cepheid is an American molecular diagnostics company that is a wholly owned subsidiary of Danaher Corporation. Its systems automate traditional nucleic acid tests. The tests can be used to identify and analyze pathogens and genetic disorders.

Health > Biotechnology and Pharmaceuticals

Domaincepheid.com

Year Founded1996

Employees5001 - 10000

Annual Revenue> $1B

Cepheid

Cepheid (including company regionals)

cepheid.com

See more website traffic and engagement information

Cepheid Revenue up to May 2026 is > 1B

revenue generated by Cepheid top domains

Cepheid top domains revenue over 3 years

Revenue for Cepheid top domains

cepheid.com> 1B

See more with Sales Intelligence

Total visits to Cepheid's top domains

Understand Cepheid market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cepheid.com138K

See more with Sales Intelligence

Avg. visit duration in Cepheid's top domains

Analyze Cepheid engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cepheid.com00:02:31

See more with Sales Intelligence

Avg. pageviews on Cepheid's top domains

See how Cepheid keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cepheid.com2.72

See more with Sales Intelligence

Cepheid top competitors by domain

Top similar sites in May 2026, ranked by their affinity

danaher.comCompany NameDanaherEmployees> 10001HQUnited States, District of Columbia, Washington, D.C.Annual revenue> $1BTotal visits319.6KFinance > Finance - Other

Top technologies used by Cepheid

These are the website technologies, by industry, used by Cepheid top domains

Advertising (24)

Google Adsense

Payment & Currencies (22)

Cart Functionality

Conversion & Analytics (14)

Google Analytics

Marketing (9)

Google Marketing Platform

More Technologies

13

See all

News & Signals from Cepheid

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFromm left Cepheid Inc as director of instrument research on Jul 1st '23.Prior to joining Promex in 2023, Fromm led research and development efforts for next-generation hardware and technology platforms at Cepheid, where he served as director of instrument research.

NewsCepheid Inc is developing workflow for rapid bacterial and fungal pathogen identification on Apr 15th '26.SUNNYVALE, Calif. and OXFORD, England, April 15, 2026 /PRNewswire/ - Cepheid, a Danaher company and a leader in molecular diagnostics for infectious diseases, and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology for real-time genomic analysis, today announced an expansion of their partnership to develop a workflow for rapid bacterial and fungal pathogen identification.